Neuronal guidance proteins in cardiovascular inflammation

Cardiovascular pathologies are often induced by inflammation. The associated changes in the inflammatory response influence vascular endothelial biology; they complicate the extent of ischaemia and reperfusion injury, direct the migration of immune competent cells and activate platelets. The initiation and progression of inflammation is regulated by the classical paradigm through the system of cytokines and chemokines. Therapeutic approaches have previously used this knowledge to control the extent of cardiovascular changes with varying degrees of success. Neuronal guidance proteins (NGPs) have emerged in recent years and have been shown to be significantly involved in the control of tissue inflammation and the mechanisms of immune cell activation. Therefore, proteins of this class might be used in the future as targets to control the extent of inflammation in the cardiovascular system. In this review, we describe the role of NGPs during cardiovascular inflammation and highlight potential therapeutic options that could be explored in the future.

Automated summary

Cardiovascular pathologies are often caused by inflammation, which affects vascular endothelial biology and can complicate ischemia, reperfusion injury, cell migration, and platelet activation. Therapeutic approaches have historically targeted cytokines and chemokines to manage cardiovascular changes, but recent research suggests that neuronal guidance proteins (NGPs) may also play a significant role in controlling inflammation and immune cell activation in the cardiovascular system.